Christine Xu, Ph.D

Senior Director
Sanofi, Morristown, NJ, USA

Poster(s):

• (T-078) Exposure-Response Modeling of Efficacy and Safety Endpoints of Sarilumab in Pediatric Patients with Polyarticular-Course Juvenile Arthritis
  Tuesday, October 21, 2025

  7:00 AM - 1:45 PM MDT